12-21176804-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006446.5(SLCO1B1):​c.388A>G​(p.Asn130Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.418 in 1,504,300 control chromosomes in the GnomAD database, including 143,945 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 23489 hom., cov: 32)
Exomes 𝑓: 0.41 ( 120456 hom. )

Consequence

SLCO1B1
NM_006446.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.275

Publications

543 publications found
Variant links:
Genes affected
SLCO1B1 (HGNC:10959): (solute carrier organic anion transporter family member 1B1) This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009]
SLCO1B1 Gene-Disease associations (from GenCC):
  • Rotor syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.6842818E-6).
BP6
Variant 12-21176804-A-G is Benign according to our data. Variant chr12-21176804-A-G is described in ClinVar as Benign. ClinVar VariationId is 259983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.761 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006446.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLCO1B1
NM_006446.5
MANE Select
c.388A>Gp.Asn130Asp
missense
Exon 5 of 15NP_006437.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLCO1B1
ENST00000256958.3
TSL:1 MANE Select
c.388A>Gp.Asn130Asp
missense
Exon 5 of 15ENSP00000256958.2
ENSG00000257062
ENST00000543498.5
TSL:4
n.*170A>G
non_coding_transcript_exon
Exon 6 of 6ENSP00000454306.1
ENSG00000257062
ENST00000543498.5
TSL:4
n.*170A>G
3_prime_UTR
Exon 6 of 6ENSP00000454306.1

Frequencies

GnomAD3 genomes
AF:
0.532
AC:
80757
AN:
151812
Hom.:
23449
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.768
Gnomad AMI
AF:
0.683
Gnomad AMR
AF:
0.469
Gnomad ASJ
AF:
0.459
Gnomad EAS
AF:
0.746
Gnomad SAS
AF:
0.516
Gnomad FIN
AF:
0.455
Gnomad MID
AF:
0.478
Gnomad NFE
AF:
0.401
Gnomad OTH
AF:
0.512
GnomAD2 exomes
AF:
0.474
AC:
118510
AN:
250172
AF XY:
0.466
show subpopulations
Gnomad AFR exome
AF:
0.776
Gnomad AMR exome
AF:
0.433
Gnomad ASJ exome
AF:
0.450
Gnomad EAS exome
AF:
0.751
Gnomad FIN exome
AF:
0.451
Gnomad NFE exome
AF:
0.404
Gnomad OTH exome
AF:
0.467
GnomAD4 exome
AF:
0.406
AC:
548628
AN:
1352370
Hom.:
120456
Cov.:
26
AF XY:
0.407
AC XY:
275414
AN XY:
676626
show subpopulations
African (AFR)
AF:
0.782
AC:
24668
AN:
31542
American (AMR)
AF:
0.437
AC:
19332
AN:
44264
Ashkenazi Jewish (ASJ)
AF:
0.441
AC:
10935
AN:
24794
East Asian (EAS)
AF:
0.702
AC:
27474
AN:
39110
South Asian (SAS)
AF:
0.466
AC:
39522
AN:
84750
European-Finnish (FIN)
AF:
0.442
AC:
22997
AN:
51984
Middle Eastern (MID)
AF:
0.460
AC:
2517
AN:
5474
European-Non Finnish (NFE)
AF:
0.371
AC:
376088
AN:
1014004
Other (OTH)
AF:
0.445
AC:
25095
AN:
56448
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.437
Heterozygous variant carriers
0
12428
24856
37285
49713
62141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11634
23268
34902
46536
58170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.532
AC:
80854
AN:
151930
Hom.:
23489
Cov.:
32
AF XY:
0.535
AC XY:
39743
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.768
AC:
31860
AN:
41484
American (AMR)
AF:
0.470
AC:
7163
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.459
AC:
1590
AN:
3464
East Asian (EAS)
AF:
0.746
AC:
3852
AN:
5166
South Asian (SAS)
AF:
0.516
AC:
2489
AN:
4824
European-Finnish (FIN)
AF:
0.455
AC:
4810
AN:
10568
Middle Eastern (MID)
AF:
0.483
AC:
142
AN:
294
European-Non Finnish (NFE)
AF:
0.401
AC:
27245
AN:
67868
Other (OTH)
AF:
0.514
AC:
1083
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1723
3445
5168
6890
8613
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.451
Hom.:
55976
Bravo
AF:
0.544
TwinsUK
AF:
0.403
AC:
1495
ALSPAC
AF:
0.397
AC:
1530
ESP6500AA
AF:
0.765
AC:
3365
ESP6500EA
AF:
0.404
AC:
3460
ExAC
AF:
0.479
AC:
58132
Asia WGS
AF:
0.656
AC:
2283
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Rotor syndrome Benign:4
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Nov 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:3
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Gilbert syndrome Benign:1
May 01, 2019
Difficult and Complicated Liver Diseases and Artificial Liver Center, Beijing You An Hospital, Capital Medical University
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:case-control

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.63
DANN
Benign
0.46
DEOGEN2
Benign
0.035
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.067
T
MetaRNN
Benign
0.0000017
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.60
N
PhyloP100
-0.28
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.023
Sift
Benign
0.45
T
Sift4G
Benign
0.56
T
Polyphen
0.0
B
Vest4
0.023
MPC
0.010
ClinPred
0.0043
T
GERP RS
-2.6
Varity_R
0.051
gMVP
0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2306283; hg19: chr12-21329738; COSMIC: COSV57012766; API